252 related articles for article (PubMed ID: 24752897)
1. The histone variant MacroH2A1 regulates target gene expression in part by recruiting the transcriptional coregulator PELP1.
Hussey KM; Chen H; Yang C; Park E; Hah N; Erdjument-Bromage H; Tempst P; Gamble MJ; Kraus WL
Mol Cell Biol; 2014 Jul; 34(13):2437-49. PubMed ID: 24752897
[TBL] [Abstract][Full Text] [Related]
2. The histone variant macroH2A1 marks repressed autosomal chromatin, but protects a subset of its target genes from silencing.
Gamble MJ; Frizzell KM; Yang C; Krishnakumar R; Kraus WL
Genes Dev; 2010 Jan; 24(1):21-32. PubMed ID: 20008927
[TBL] [Abstract][Full Text] [Related]
3. PELP1 oncogenic functions involve CARM1 regulation.
Mann M; Cortez V; Vadlamudi R
Carcinogenesis; 2013 Jul; 34(7):1468-75. PubMed ID: 23486015
[TBL] [Abstract][Full Text] [Related]
4. The transcriptional corepressor, PELP1, recruits HDAC2 and masks histones using two separate domains.
Choi YB; Ko JK; Shin J
J Biol Chem; 2004 Dec; 279(49):50930-41. PubMed ID: 15456770
[TBL] [Abstract][Full Text] [Related]
5. Significance of PELP1/HDAC2/miR-200 regulatory network in EMT and metastasis of breast cancer.
Roy SS; Gonugunta VK; Bandyopadhyay A; Rao MK; Goodall GJ; Sun LZ; Tekmal RR; Vadlamudi RK
Oncogene; 2014 Jul; 33(28):3707-16. PubMed ID: 23975430
[TBL] [Abstract][Full Text] [Related]
6. PELP1: Structure, biological function and clinical significance.
Sareddy GR; Vadlamudi RK
Gene; 2016 Jul; 585(1):128-134. PubMed ID: 26997260
[TBL] [Abstract][Full Text] [Related]
7. Modulation of in situ estrogen synthesis by proline-, glutamic acid-, and leucine-rich protein-1: potential estrogen receptor autocrine signaling loop in breast cancer cells.
Rajhans R; Nair HB; Nair SS; Cortez V; Ikuko K; Kirma NB; Zhou D; Holden AE; Brann DW; Chen S; Tekmal RR; Vadlamudi RK
Mol Endocrinol; 2008 Mar; 22(3):649-64. PubMed ID: 18079323
[TBL] [Abstract][Full Text] [Related]
8. Potential role of a novel transcriptional coactivator PELP1 in histone H1 displacement in cancer cells.
Nair SS; Mishra SK; Yang Z; Balasenthil S; Kumar R; Vadlamudi RK
Cancer Res; 2004 Sep; 64(18):6416-23. PubMed ID: 15374949
[TBL] [Abstract][Full Text] [Related]
9. Inflammation-induced PELP1 expression promotes tumorigenesis by activating GM-CSF paracrine secretion in the tumor microenvironment.
Vuttaradhi VK; Ezhil I; Ramani D; Kanumuri R; Raghavan S; Balasubramanian V; Saravanan R; Kanakarajan A; Joseph LD; Pitani RS; Sundaram S; Sjolander A; Venkatraman G; Rayala SK
J Biol Chem; 2022 Jan; 298(1):101406. PubMed ID: 34774800
[TBL] [Abstract][Full Text] [Related]
10. Targeting the PELP1-KDM1 axis as a potential therapeutic strategy for breast cancer.
Cortez V; Mann M; Tekmal S; Suzuki T; Miyata N; Rodriguez-Aguayo C; Lopez-Berestein G; Sood AK; Vadlamudi RK
Breast Cancer Res; 2012 Jul; 14(4):R108. PubMed ID: 22812534
[TBL] [Abstract][Full Text] [Related]
11. Interaction of transcription factor AP-2 gamma with proto-oncogene PELP1 promotes tumorigenesis by enhancing RET signaling.
Liu J; Liu Z; Li M; Tang W; Pratap UP; Luo Y; Altwegg KA; Li X; Zou Y; Zhu H; Sareddy GR; Viswanadhapalli S; Vadlamudi RK
Mol Oncol; 2021 Apr; 15(4):1146-1161. PubMed ID: 33269540
[TBL] [Abstract][Full Text] [Related]
12. PELP1 oncogenic functions involve alternative splicing via PRMT6.
Mann M; Zou Y; Chen Y; Brann D; Vadlamudi R
Mol Oncol; 2014 Mar; 8(2):389-400. PubMed ID: 24447537
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of proline, glutamic acid, leucine rich protein 1 (PELP1) in triple-negative breast cancer: a retrospective study on 129 cases.
Zhang Y; Dai J; McNamara KM; Bai B; Shi M; Chan MS; Liu M; Sasano H; Wang X; Li X; Liu L; Ma Y; Cao S; Xing Y; Zhao B; Song Y; Wang L
BMC Cancer; 2015 Oct; 15():699. PubMed ID: 26472563
[TBL] [Abstract][Full Text] [Related]
14. Therapeutic targeting of PELP1 prevents ovarian cancer growth and metastasis.
Chakravarty D; Roy SS; Babu CR; Dandamudi R; Curiel TJ; Vivas-Mejia P; Lopez-Berestein G; Sood AK; Vadlamudi RK
Clin Cancer Res; 2011 Apr; 17(8):2250-9. PubMed ID: 21421858
[TBL] [Abstract][Full Text] [Related]
15. Regulation of aromatase induction by nuclear receptor coregulator PELP1.
Vadlamudi RK; Rajhans R; Chakravarty D; Nair BC; Nair SS; Evans DB; Chen S; Tekmal RR
J Steroid Biochem Mol Biol; 2010 Feb; 118(4-5):211-8. PubMed ID: 19800002
[TBL] [Abstract][Full Text] [Related]
16. Molecular cloning and characterization of PELP1, a novel human coregulator of estrogen receptor alpha.
Vadlamudi RK; Wang RA; Mazumdar A; Kim Y; Shin J; Sahin A; Kumar R
J Biol Chem; 2001 Oct; 276(41):38272-9. PubMed ID: 11481323
[TBL] [Abstract][Full Text] [Related]
17. The histone variant macroH2A1.1 regulates RNA polymerase II-paused genes within defined chromatin interaction landscapes.
Recoules L; Heurteau A; Raynal F; Karasu N; Moutahir F; Bejjani F; Jariel-Encontre I; Cuvier O; Sexton T; Lavigne AC; Bystricky K
J Cell Sci; 2022 Apr; 135(7):. PubMed ID: 35362516
[TBL] [Abstract][Full Text] [Related]
18. MacroH2A1 knockdown effects on the Peg3 imprinted domain.
Choo JH; Kim JD; Kim J
BMC Genomics; 2007 Dec; 8():479. PubMed ID: 18166131
[TBL] [Abstract][Full Text] [Related]
19. SETDB1 interactions with PELP1 contributes to breast cancer endocrine therapy resistance.
Liu Z; Liu J; Ebrahimi B; Pratap UP; He Y; Altwegg KA; Tang W; Li X; Lai Z; Chen Y; Shen L; Sareddy GR; Viswanadhapalli S; Tekmal RR; Rao MK; Vadlamudi RK
Breast Cancer Res; 2022 Apr; 24(1):26. PubMed ID: 35395812
[TBL] [Abstract][Full Text] [Related]
20. The pattern of proline, glutamic acid, and leucine-rich protein 1 expression in Chinese women with primary breast cancer.
Zhang Y; Wang P; Shi M; Sasano H; Chan MS; Dai J; Guo L; Liu M; Wang X; Ma Y; Wang L
Int J Biol Markers; 2014 Mar; 29(1):e1-7. PubMed ID: 24627205
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
